KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityConstruction in ProgressFed Funds SoldInterest DepositsLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Southern First Bancshares (SFST) Cash & Equivalents (2016 - 2026)

Southern First Bancshares (SFST) has disclosed Cash & Equivalents for 11 consecutive years, with $342.8 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 12.36% year-over-year to $342.8 million; the TTM value through Mar 2026 reached $342.8 million, up 12.36%, while the annual FY2025 figure was $269.6 million, 65.53% up from the prior year.
  • Cash & Equivalents hit $342.8 million in Q1 2026 for Southern First Bancshares, up from $269.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $342.8 million in Q1 2026 and bottomed at $9.4 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $200.1 million, with a median of $194.8 million recorded in 2024.
  • On a YoY basis, Cash & Equivalents climbed as much as 1631.11% in 2024 and fell as far as 38.54% in 2024.
  • Southern First Bancshares' Cash & Equivalents stood at $13.9 million in 2022, then crashed by 32.23% to $9.4 million in 2023, then surged by 1631.11% to $162.9 million in 2024, then surged by 65.53% to $269.6 million in 2025, then increased by 27.15% to $342.8 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $342.8 million, $269.6 million, and $282.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.